ORGS
Orgenesis Inc
Price:  
0.60 
USD
Volume:  
486,287.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORGS WACC - Weighted Average Cost of Capital

The WACC of Orgenesis Inc (ORGS) is 6.3%.

The Cost of Equity of Orgenesis Inc (ORGS) is 24.45%.
The Cost of Debt of Orgenesis Inc (ORGS) is 4.25%.

Range Selected
Cost of equity 16.30% - 32.60% 24.45%
Tax rate 0.90% - 1.30% 1.10%
Cost of debt 4.00% - 4.50% 4.25%
WACC 5.2% - 7.4% 6.3%
WACC

ORGS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2.7 4.96
Additional risk adjustments 0.0% 0.5%
Cost of equity 16.30% 32.60%
Tax rate 0.90% 1.30%
Debt/Equity ratio 8.63 8.63
Cost of debt 4.00% 4.50%
After-tax WACC 5.2% 7.4%
Selected WACC 6.3%

ORGS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for ORGS:

cost_of_equity (24.45%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (2.7) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.